A 6-Year-Old Girl, the World's First In-Brain Gene-Editing Trial, and a Top Nature Paper: A Tragedy That Shouldn't Be Forgotten
AI in pharma, The business of pharma, Company histories, How drugs come to be, People US China biotech, Policy regulation Johnny Wang AI in pharma, The business of pharma, Company histories, How drugs come to be, People US China biotech, Policy regulation Johnny Wang

A 6-Year-Old Girl, the World's First In-Brain Gene-Editing Trial, and a Top Nature Paper: A Tragedy That Shouldn't Be Forgotten

A 6-year-old girl with a non-fatal genetic condition became the world's first patient to receive in-brain base editing. Seven days later she died — and her death stayed hidden for over a year, even as the research appeared in Nature. Here's what happened, from the primary sources.

Read More